The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukemia (ALL): A Children’s Oncology Group study.
 
Susan R. Rheingold
Employment - Endo Pharmaceuticals (I)
Stock and Other Ownership Interests - Endo Pharmaceuticals (I)
Travel, Accommodations, Expenses - MedImmune
 
James Whitlock
Honoraria - EUSA Pharma
Consulting or Advisory Role - EUSA Pharma
Research Funding - GlaxoSmithKline
 
Sarah K. Tasian
No Relationships to Disclose
 
David T. Teachey
No Relationships to Disclose
 
Michael J. Borowitz
No Relationships to Disclose
 
Xiaowei Liu
No Relationships to Disclose
 
Charlotte H. Ahern
No Relationships to Disclose
 
Charles Minard
No Relationships to Disclose
 
Elizabeth Fox
No Relationships to Disclose
 
Brenda Weigel
Travel, Accommodations, Expenses - Genentech; Lilly/ImClone; Roche/Genentech
 
Susan Blaney
Research Funding - Genentech (Inst)